112 related articles for article (PubMed ID: 31641096)
1. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
Han B; Zhang Q; Li G; Zhang R; Li H
Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
[TBL] [Abstract][Full Text] [Related]
2. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
[TBL] [Abstract][Full Text] [Related]
4. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
Li BD; Gruner JS; Abreo F; Johnson LW; Yu H; Nawas S; McDonald JC; DeBenedetti A
Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.
Jiang XM; Yu XN; Huang RZ; Zhu HR; Chen XP; Xiong J; Chen ZY; Huang XX; Shen XZ; Zhu JM
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2309-17. PubMed ID: 27601163
[TBL] [Abstract][Full Text] [Related]
9. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
10. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
[TBL] [Abstract][Full Text] [Related]
14. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma.
Wang XL; Cai HP; Ge JH; Su XF
World J Gastroenterol; 2012 May; 18(20):2540-4. PubMed ID: 22654452
[TBL] [Abstract][Full Text] [Related]
15. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.
McClusky DR; Chu Q; Yu H; Debenedetti A; Johnson LW; Meschonat C; Turnage R; McDonald JC; Abreo F; Li BD
Ann Surg; 2005 Oct; 242(4):584-90; discussion 590-2. PubMed ID: 16192819
[TBL] [Abstract][Full Text] [Related]
16. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.
Byrnes KW; DeBenedetti A; Holm NT; Luke J; Nunez J; Chu QD; Meschonat C; Abreo F; Johnson LW; Li BD
J Am Coll Surg; 2007 May; 204(5):925-33; discussion 933-4. PubMed ID: 17481512
[TBL] [Abstract][Full Text] [Related]
17. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
[TBL] [Abstract][Full Text] [Related]
18. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.
Pettersson F; Yau C; Dobocan MC; Culjkovic-Kraljacic B; Retrouvey H; Puckett R; Flores LM; Krop IE; Rousseau C; Cocolakis E; Borden KL; Benz CC; Miller WH
Clin Cancer Res; 2011 May; 17(9):2874-84. PubMed ID: 21415224
[TBL] [Abstract][Full Text] [Related]
20. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
